+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transdermal Drug Delivery Market 2025-2029- Product Image
Transdermal Drug Delivery Market 2025-2029- Product Image
New

Transdermal Drug Delivery Market 2025-2029

  • PDF Icon

    Report

  • 228 Pages
  • August 2025
  • Region: Global
  • TechNavio
  • ID: 5912579
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The transdermal drug delivery market is forecasted to grow by USD 2.66 billion during 2024-2029, accelerating at a CAGR of 5.1% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The transdermal drug delivery market is segmented as below:

By Application

  • Analgesics
  • Neurological disorders
  • Hormone replacement therapy
  • Cardiovascular disorders
  • Others

By Type

  • Transdermal patches
  • Transdermal semisolids

By Technology

  • Microneedles
  • Iontophoresis
  • Sonophoresis
  • Electroporation

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.

The report on the transdermal drug delivery market covers the following areas:

  • Transdermal Drug Delivery Market sizing
  • Transdermal Drug Delivery Market forecast
  • Transdermal Drug Delivery Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson Services Inc., Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Transdermal Drug Delivery Market 2019 - 2023
Historic Market Size - Data Table on Global Transdermal Drug Delivery Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in the global transdermal drug delivery market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Analgesics - Market size and forecast 2024-2029
Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
8.4 Neurological disorders - Market size and forecast 2024-2029
Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
8.5 Hormone replacement therapy - Market size and forecast 2024-2029
Chart on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Chart on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
Data Table on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
8.6 Cardiovascular disorders - Market size and forecast 2024-2029
Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Transdermal patches - Market size and forecast 2024-2029
Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
9.4 Transdermal semisolids - Market size and forecast 2024-2029
Chart on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Data Table on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Chart on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Technology
10.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
10.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
10.3 Microneedles - Market size and forecast 2024-2029
Chart on Microneedles - Market size and forecast 2024-2029 ($ million)
Data Table on Microneedles - Market size and forecast 2024-2029 ($ million)
Chart on Microneedles - Year-over-year growth 2024-2029 (%)
Data Table on Microneedles - Year-over-year growth 2024-2029 (%)
10.4 Iontophoresis - Market size and forecast 2024-2029
Chart on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Data Table on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Chart on Iontophoresis - Year-over-year growth 2024-2029 (%)
Data Table on Iontophoresis - Year-over-year growth 2024-2029 (%)
10.5 Sonophoresis - Market size and forecast 2024-2029
Chart on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Data Table on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Chart on Sonophoresis - Year-over-year growth 2024-2029 (%)
Data Table on Sonophoresis - Year-over-year growth 2024-2029 (%)
10.6 Electroporation - Market size and forecast 2024-2029
Chart on Electroporation - Market size and forecast 2024-2029 ($ million)
Data Table on Electroporation - Market size and forecast 2024-2029 ($ million)
Chart on Electroporation - Year-over-year growth 2024-2029 (%)
Data Table on Electroporation - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.12 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
3M Co.
3M Co. - Overview
3M Co. - Business segments
3M Co. - Key news
3M Co. - Key offerings
3M Co. - Segment focus
SWOT
15.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.6 Croda International Plc
Croda International Plc - Overview
Croda International Plc - Business segments
Croda International Plc - Key offerings
Croda International Plc - Segment focus
SWOT
15.7 Hisamitsu Pharmaceutical Co. Inc.
Hisamitsu Pharmaceutical Co. Inc. - Overview
Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Hisamitsu Pharmaceutical Co. Inc. - Key offerings
SWOT
15.8 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.9 Kindeva Drug Delivery L.P.
Kindeva Drug Delivery L.P. - Overview
Kindeva Drug Delivery L.P. - Product / Service
Kindeva Drug Delivery L.P. - Key offerings
SWOT
15.10 Luye Pharma Group Ltd.
Luye Pharma Group Ltd. - Overview
Luye Pharma Group Ltd. - Business segments
Luye Pharma Group Ltd. - Key offerings
Luye Pharma Group Ltd. - Segment focus
SWOT
15.11 Medherant Ltd.
Medherant Ltd. - Overview
Medherant Ltd. - Product / Service
Medherant Ltd. - Key offerings
SWOT
15.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.13 ProSolus Inc.
ProSolus Inc. - Overview
ProSolus Inc. - Product / Service
ProSolus Inc. - Key offerings
SWOT
15.14 Purdue Pharma LP
Purdue Pharma LP - Overview
Purdue Pharma LP - Product / Service
Purdue Pharma LP - Key offerings
SWOT
15.15 Sparsha Pharma International Pvt. Ltd.
Sparsha Pharma International Pvt. Ltd. - Overview
Sparsha Pharma International Pvt. Ltd. - Product / Service
Sparsha Pharma International Pvt. Ltd. - Key offerings
SWOT
15.16 Teikoku Seiyaku Co. Ltd.
Teikoku Seiyaku Co. Ltd. - Overview
Teikoku Seiyaku Co. Ltd. - Product / Service
Teikoku Seiyaku Co. Ltd. - Key offerings
SWOT
15.17 UCB SA
UCB SA - Overview
UCB SA - Product / Service
UCB SA - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Transdermal Drug Delivery Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Technology Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Application - Market share 2024-2029 (%)
Exhibits 39: Data Table on Application - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Application
Exhibits 41: Data Table on Comparison by Application
Exhibits 42: Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Analgesics - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Hormone replacement therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Hormone replacement therapy - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Application ($ million)
Exhibits 63: Data Table on Market opportunity by Application ($ million)
Exhibits 64: Chart on Type - Market share 2024-2029 (%)
Exhibits 65: Data Table on Type - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by Type
Exhibits 67: Data Table on Comparison by Type
Exhibits 68: Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Transdermal semisolids - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Transdermal semisolids - Year-over-year growth 2024-2029 (%)
Exhibits 76: Market opportunity by Type ($ million)
Exhibits 77: Data Table on Market opportunity by Type ($ million)
Exhibits 78: Chart on Technology - Market share 2024-2029 (%)
Exhibits 79: Data Table on Technology - Market share 2024-2029 (%)
Exhibits 80: Chart on Comparison by Technology
Exhibits 81: Data Table on Comparison by Technology
Exhibits 82: Chart on Microneedles - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Microneedles - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Microneedles - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Microneedles - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Iontophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Iontophoresis - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Iontophoresis - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Sonophoresis - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Sonophoresis - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Sonophoresis - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Electroporation - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Electroporation - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Electroporation - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Electroporation - Year-over-year growth 2024-2029 (%)
Exhibits 98: Market opportunity by Technology ($ million)
Exhibits 99: Data Table on Market opportunity by Technology ($ million)
Exhibits 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 103: Chart on Geographic comparison
Exhibits 104: Data Table on Geographic comparison
Exhibits 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 161: Market opportunity By Geographical Landscape ($ million)
Exhibits 162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 163: Impact of drivers and challenges in 2024 and 2029
Exhibits 164: Overview on criticality of inputs and factors of differentiation
Exhibits 165: Overview on factors of disruption
Exhibits 166: Impact of key risks on business
Exhibits 167: Companies covered
Exhibits 168: Company ranking index
Exhibits 169: Matrix on companies position and classification
Exhibits 170: 3M Co. - Overview
Exhibits 171: 3M Co. - Business segments
Exhibits 172: 3M Co. - Key news
Exhibits 173: 3M Co. - Key offerings
Exhibits 174: 3M Co. - Segment focus
Exhibits 175: SWOT
Exhibits 176: Boehringer Ingelheim International GmbH - Overview
Exhibits 177: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 178: Boehringer Ingelheim International GmbH - Key news
Exhibits 179: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 180: SWOT
Exhibits 181: Croda International Plc - Overview
Exhibits 182: Croda International Plc - Business segments
Exhibits 183: Croda International Plc - Key offerings
Exhibits 184: Croda International Plc - Segment focus
Exhibits 185: SWOT
Exhibits 186: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits 187: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibits 188: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits 189: SWOT
Exhibits 190: Johnson and Johnson Services Inc. - Overview
Exhibits 191: Johnson and Johnson Services Inc. - Business segments
Exhibits 192: Johnson and Johnson Services Inc. - Key news
Exhibits 193: Johnson and Johnson Services Inc. - Key offerings
Exhibits 194: Johnson and Johnson Services Inc. - Segment focus
Exhibits 195: SWOT
Exhibits 196: Kindeva Drug Delivery L.P. - Overview
Exhibits 197: Kindeva Drug Delivery L.P. - Product / Service
Exhibits 198: Kindeva Drug Delivery L.P. - Key offerings
Exhibits 199: SWOT
Exhibits 200: Luye Pharma Group Ltd. - Overview
Exhibits 201: Luye Pharma Group Ltd. - Business segments
Exhibits 202: Luye Pharma Group Ltd. - Key offerings
Exhibits 203: Luye Pharma Group Ltd. - Segment focus
Exhibits 204: SWOT
Exhibits 205: Medherant Ltd. - Overview
Exhibits 206: Medherant Ltd. - Product / Service
Exhibits 207: Medherant Ltd. - Key offerings
Exhibits 208: SWOT
Exhibits 209: Novartis AG - Overview
Exhibits 210: Novartis AG - Business segments
Exhibits 211: Novartis AG - Key news
Exhibits 212: Novartis AG - Key offerings
Exhibits 213: Novartis AG - Segment focus
Exhibits 214: SWOT
Exhibits 215: ProSolus Inc. - Overview
Exhibits 216: ProSolus Inc. - Product / Service
Exhibits 217: ProSolus Inc. - Key offerings
Exhibits 218: SWOT
Exhibits 219: Purdue Pharma LP - Overview
Exhibits 220: Purdue Pharma LP - Product / Service
Exhibits 221: Purdue Pharma LP - Key offerings
Exhibits 222: SWOT
Exhibits 223: Sparsha Pharma International Pvt. Ltd. - Overview
Exhibits 224: Sparsha Pharma International Pvt. Ltd. - Product / Service
Exhibits 225: Sparsha Pharma International Pvt. Ltd. - Key offerings
Exhibits 226: SWOT
Exhibits 227: Teikoku Seiyaku Co. Ltd. - Overview
Exhibits 228: Teikoku Seiyaku Co. Ltd. - Product / Service
Exhibits 229: Teikoku Seiyaku Co. Ltd. - Key offerings
Exhibits 230: SWOT
Exhibits 231: UCB SA - Overview
Exhibits 232: UCB SA - Product / Service
Exhibits 233: UCB SA - Key offerings
Exhibits 234: SWOT
Exhibits 235: Viatris Inc. - Overview
Exhibits 236: Viatris Inc. - Business segments
Exhibits 237: Viatris Inc. - Key news
Exhibits 238: Viatris Inc. - Key offerings
Exhibits 239: Viatris Inc. - Segment focus
Exhibits 240: SWOT
Exhibits 241: Inclusions checklist
Exhibits 242: Exclusions checklist
Exhibits 243: Currency conversion rates for US$
Exhibits 244: Research methodology
Exhibits 245: Information sources
Exhibits 246: Data validation
Exhibits 247: Validation techniques employed for market sizing
Exhibits 248: Data synthesis
Exhibits 249: 360 degree market analysis
Exhibits 250: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global transdermal drug delivery market: 3M Co., Boehringer Ingelheim International GmbH, Croda International PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson Services Inc., Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing interest in transdermal medicines."

According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co.
  • Boehringer Ingelheim International GmbH
  • Croda International Plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • Johnson and Johnson Services Inc.
  • Kindeva Drug Delivery L.P.
  • Luye Pharma Group Ltd.
  • Medherant Ltd.
  • Novartis AG
  • ProSolus Inc.
  • Purdue Pharma LP
  • Rusan Pharma Ltd.
  • Sparsha Pharma International Pvt. Ltd.
  • Teikoku Seiyaku Co. Ltd.
  • UCB SA
  • Viatris Inc.

Related Topics

Related Reports

Transdermal Drug Delivery System Market by Product Type (Creams, Gels, Patches), Active Ingredient (Estrogen, Fentanyl, Nicotine), Technology, Delivery Mechanism, Application, End User - Global Forecast 2025-2030 - Product Image

Transdermal Drug Delivery System Market by Product Type (Creams, Gels, Patches), Active Ingredient (Estrogen, Fentanyl, Nicotine), Technology, Delivery Mechanism, Application, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 431 Pages
  • Global
From
Transdermal Drug Delivery Systems (TDDS) Market - Forecasts from 2025 to 2030 - Product Image

Transdermal Drug Delivery Systems (TDDS) Market - Forecasts from 2025 to 2030

  • Report
  • 144 Pages
  • Global
From
Transdermal Drug Delivery Systems Global Market Report 2025 - Product Image

Transdermal Drug Delivery Systems Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Transdermal Drug Delivery - Global Strategic Business Report - Product Image

Transdermal Drug Delivery - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.